the precore-core (preC-C) promoter have been detected in HBV infections without serological markers. To address whether the mutations are responsible for the reduced production of virus antigens, either an 8 bp (8d, position 1763 to 1770) or a 20 bp (20d, 1753 to 1772) deletion was created in a wild-type (wt) HBV clone. Both mutations cause premature termination of the overlapping X ORF. When introduced into HepG2 cells, both mutants produced reduced amounts of HBsAg, HBcAg and HBeAg, but released the same or more virionassociated DNA compared with the wt. A co-transfection of the 20d mutant with a small amount of intact X gene resulted in a 3-fold increase of HBcAg
Introduction
Hepatitis B virus (HBV) DNA with deletions in the precorecore (preC-C) promoter overlapping the X gene has been detected in a variety of hepatitis cases, including chronic hepatitis B (Feitelson et al., 1991 Repp et al., 1992) , HBsAg-negative post-transfusion hepatitis (Feitelson, 1994) , HBV infection with no serological marker (Preisler-Adams et al., 1993 and anti-HBe seropositive infections (Kim et al., 1992 ; Laskus et al., 1994 ; Okamoto et al., 1994) . Infection solely by a deletion mutant results in low titres of HBV DNA in serum. In contrast, HBV DNA titres vary among those infected with a quasispecies including both mutant and wildtype (wt) viruses (Okamoto et al., 1994) . production compared to transfection with either the 20d or wt alone. When the promoter region was cloned into CAT plasmids, the 8d preC promoter showed weak activity and its initiation site was shifted 6 to 10 bp downstream. The preC promoter activity of 20d was not detectable by CAT ELISA and 5h RACE. The levels of C transcripts of both mutants were higher than that of the wt, and their start sites were not altered. Therefore, the deletions cause the reduction of HBsAg, HBcAg and HBeAg although the mutant viruses can still replicate in cultured cells. The reduction of HBeAg is due to both the reduced preC promoter activity and the defect in HBx. The reduction of HBcAg is due to the disrupted X gene, despite augmented C promoter activity.
The HBx transcription factor, a 154 amino acid (aa) product of the X gene, trans-activates gene expression from diverse viral and cellular genes (Twu & Schloemer, 1987 ; Trusnt et al., 1995) , including HBV C and S (Nakatake et al., 1993 ; Spandau & Lee, 1988 ; Colgrove et al., 1989) . It has been demonstrated that HBx lacking the carboxyl-terminal 24 aa cannot act as a transcriptional trans-activator (Runkel et al., 1993 ; Takada & Koike, 1994) . This region is associated with most of the X gene deletion mutations detected in clinical samples. Therefore, deletions in this region are considered to be responsible for the reduced viral antigen production as well as several types of disease progression (for a review, see Feitelson, 1994) .
The preC gene product, HBeAg precursor, is translated from 3n5 kb over-genome length transcripts, which initiate 22 to 28 bp upstream from the preC initiation codon (Weimer et al., 1987 ; Yaginuma & Koike, 1989) . The precursor loses 19 amino-terminal aa and 36 (or 34 in several subtypes bearing a 6 bp shorter C gene) carboxyl-terminal aa for secretion from infected hepatocytes (Bruss & Gerlich, 1988 ; Jean-Jean et al., 1989) . Although the biological function of HBeAg is still unclear, patients with the HBeAg marker generally have high levels of virus and higher rates of transmission than those who are anti-HBe-seropositive (Okada et al., 1976 ; Alter et al., 1976) .
The C gene product, HBcAg, is translated from another 3n5 kb transcript, of which the 5h end is 29 to 35 nucleotides further downstream than that of the preC mRNA, and in which the preC initiation codon is absent. This transcript also serves as the mRNA for both the DNA polymerase-reverse transcriptase and the pregenome (Mason et al., 1982 ; Summers & Mason, 1982 ; Seeger et al., 1986 ; Nassal et al., 1990 ; Ou et al., 1990) . Thus, mutations affecting levels of C transcripts most likely play a role in pathology.
Transcription of the C mRNA is controlled by an upstream regulatory element and the basic C promoter (position 1643 to 1849) (Yaginuma & Koike, 1989 ; Yuh et al., 1992) as well as a negative regulatory element (1611 to 1634) (Lo & Ting, 1994) . The function of this C promoter region in the transcription of overlapping preC mRNA has not been examined in detail.
In this study, it was demonstrated that the 8 bp (1763 to 1770, between the second and third AT-rich regions) and 20 bp (1753 to 1772, encompassing the first and second ATrich regions) deletion mutations in the preC-C promoter of dimeric HBV DNA are responsible for the reduced production of HBsAg, HBcAg and HBeAg in transfected HepG2 cells. Also, it was found that the mutations cause remarkable reductions in preC promoter activity as well as a small enhancement of C promoter activity.
Methods
Plasmids carrying a tandem dimer of whole-genome HBV DNA. Plasmid pYW8d carries an HBV DNA with an 8 bp deletion (8d) from 1763 to 1770 ( Fig. 1 ). This was produced by PCR-based sitedirected mutagenesis (Landt et al., 1990) of plasmid pPYW310, a pUC119 having a 3182 bp complete HBV genome (subtype ayw) at the PstI site. The HBV DNA was cloned from the serum of an HBeAg-positive carrier (Okamoto et al., 1990) . The two first-step PCRs were performed with a forward primer B026 (5h GACAACTCTGTTGTCCTCTCC) and a mutated reverse primer B058 (5h AGCCTCCTAGTATTTAATCTA-ATC), and a reverse primer B046 (5h TGCTCAGGAGACTCTAAGGC) and a mutated forward primer B057 (5h GATTAGATTAAATACTAG-GGAGGCT). The second-round PCR products obtained using primers B026 and B046 encompassed positions 1333 to 2040 of HBV. Both ends of the 1n1 kb fragments were digested with NcoI and SacII, and replaced with the wt NcoI-SacII fragment of pPYW310. pYW20d, bearing a 20 bp deletion (20d) from 1753 to 1772, was made as described above using the monomer template pYW8d and mutated primers B075 (GGGGAGGA-GACTAGGAGGCTGTAGGCATAA) and B076 (AGCCTCCTAGTC-TCCTCCCCCAACTCCTCC). The 6n4 kb replication-competent homogeneous tandem dimer of the HBV genome was cloned at the unique PstI site of pUC119 and designated p2UCP (from pPYW310), p2W8d (pYW8d) or p2W20d (pYW20d). Plasmid ∆C has a tandem dimer with a 2 bp deletion at positions 2003 and 2004 in the C ORF (Okamoto et al., 1990) , and was used as a negative control for HBcAg and HBeAg production. This frame-shift mutation alters the C protein sequence from aa 35 to 45 where it terminates prematurely. The relative orientations of the viral DNA and vector DNA were identical for the dimer constructs.
To construct pBasic.d5hCAT, in which 38 bp were deleted from the 5h UTR of the chloramphenicol acetyltransferase (CAT) gene of pCAT-Basic (Promega), part of the CAT ORF encompassing the region from the initiation codon to a unique NcoI site was amplified by PCR using primers B077 (5h GACTCTAGACTAAAATGGAGAAAAAAATCA) and B078 (5h CAGCACCTTGTCGCCTTGCG), and ligated with the larger fragment of XbaIand NcoI-digested pCAT-Basic DNA. For p8d.d5hCAT and p20d.d5hCAT, a DNA fragment from 1630 to 1799 of each wt or mutated HBV DNA was amplified by PCR using primers B067 (5h GGAGTCGACCAAATCTTGCCCAAGGTCT) and B068 (5h TGC-GTCGACCAATTTATGCCTACAGCC). Both primers contain an introduced SalI site, and the amplified products were cloned into the SalI site of pBasic.d5hCAT (see Fig. 4A ). For p8d.79.CAT and p20d.79.CAT, each HBV DNA between positions 1630 and 1846 was amplified with primers B067 and B079 (5h CAGATCTAGAGATGATTAGGCAGAGGTG), digested with SalI and XbaI, and then cloned into the SalI-XbaI digest of the pCAT-Basic vector.
Transfection. HepG2 human hepatoma cells (Aden et al., 1979) were cultured in 60 mm dishes containing DMEM supplemented with 10 % calf serum (CS). Recombinant plasmids were introduced into the cells using polycationic lipids (LipofectAMINE, Gibco). For triplicate transfections, 15n0 µg of plasmid carrying HBV genomes and 3n0 µg of pTKGH (Selden et al., 1986) were mixed with 90 µl of the lipid solution in 1n2 ml of reduced serum medium (Gibco). The mixture was incubated at 22 mC for 30 min, then diluted with 4n8 ml of the reduced serum medium. Two ml of this diluted mixture per dish was overlaid on the cells. After 6 h of incubation at 37 mC, 2n0 ml of DMEM containing 20 % CS was added, and the dishes were incubated for a further 12 h. Then the culture medium was replaced with 4 ml of fresh DMEM containing 10 % CS.
ELISA of HBV antigens, human growth hormone (hGH) and CAT. For ELISA of the cell lysates for HBV antigens, cells were rinsed with 5 ml of PBS three times, scraped into 1 ml of PBS and pelleted by brief centrifugation. The cell pellet was suspended in 200 ml of 0n25 M Tris-HCl, pH 7n5, and stored at k70 mC. For ELISA, an equal volume of 2i lysis solution consisting of 150 mM NaCl, 20 mM EDTA, pH 8n0, 1 mM PMSF (Sigma) was added to the suspension, and the mixture was vortexed for 15 s and centrifuged at 12 000 g for 3 min. Part of the supernatant was then diluted to an appropriate concentration to fit within the linear range of light absorbance. HBsAg was tested using anti-HBs horse serum as an immobilized antibody, and sandwiched with a monoclonal antibody (MAb) against the common determinants of HBsAg (No. 824) (Usuda et al., 1986) . Hepatitis B nucleocapsid antigen (HBcAg), representing viral C particles, was determined by sandwiching it between two MAbs of distinct specificity (No. 3120 and No. 3105) (Takahashi et al., 1983) . Similarly, HBeAg was determined by sandwiching it between two MAbs (No. 904 and No. 905) (Takahashi et al., 1983) . The amount of hGH in the culture supernatant was determined with an hGH ELISA kit (Boehringer Mannheim) and o-phenylenediamine (OPD) substrate (Sigma).
For CAT-ELISA, HepG2 cells in a 60 mm dish were transfected with 5 µg of CAT plasmid along with 1 µg of pTKGH with polycationic lipids. Two days after transfection, the cells were harvested and extract was prepared as described for the HBcAg ELISA. The CAT polypeptide was quantified with a CAT-ELISA kit (Boehringer Mannheim) and OPD.
Southern blotting. To isolate encapsidated viral DNA, 4 ml of culture medium was centrifuged at 273 000 g for 3 h. The pellet was suspended in 1 ml PBS, overlaid on 3n5 ml of 20 % sucrose-PBS, and centrifuged at 273 000 g for 3 h. Tris-HCl, pH 8n8, CaCl # and staphylococcal nuclease (Sigma) were added to the resulting pellet to provide final concentrations of 10 mM, 5 mM and 1 U\ml in 1 ml, respectively. The BEIA HBV X and preC-C promoter deletion mutation HBV X and preC-C promoter deletion mutation (Yuh et al., 1992) , liver-specific enhancer II (Enh II) (Yee, 1989 ; Wang et al., 1990) , and negative regulatory element (NRE) (Lo & Ting, 1994) are represented. Transcriptional initiation sites for the preC and C mRNAs of p2UCP, DR1 and the pregenome encapsidation signal (ε) (Nassal et al., 1990 ; Junker-Niepman et al., 1990 ; Pollack & Ganem, 1993) reaction mixture was diluted to 0n5% (w\v) in SDS and 0n2 mg\ml in proteinase K, and further incubated at 55 mC for 2 h. DNA was extracted with phenol and chloroform, and precipitated with ethanol. The DNA was then completely digested with DpnI, subjected to electrophoresis on 1n0 % agarose gel and blotted onto a nylon filter membrane. Hybridization was carried out with PCR-amplified HBV DNA (spanning positions 747 to 1823 and 2413 to 3182\1 to 197 of pPYW310) labelled with [$#P]dCTP, and the filters were washed under highly stringent conditions. Radioactivity of specific bands was counted with a BAS 2000 image analyser (Fuji film).
PCR and restriction fragment length polymorphism of progeny virus DNA of the mixed transfection. DNA was extracted from the culture medium of cells co-transfected with p2W20d and p2UCP as described above, and contaminating plasmid DNA harbouring the HBV genome was digested extensively with the methylationsensitive restriction endonuclease DpnI. Thus, the DNA replicated in transfected cells, but not plasmid DNA, could be amplified by PCR using primers which anneal to the region outside the DpnI sites. DpnI sites are located at positions 1401 and 1985 (see Fig. 3A ). HBV DNA from position 1260 to 2046, encompassing the preC-C promoter, was amplified by PCR (25 cycles) using primers B26 and B46, digested with StyI and electrophoresed in 5 % agarose gel. StyI sites were located at positions 1372, 1642 and 1882. The amplified progeny DNA of p2UCP and p2W20d contained 240 and 220 bp StyI fragments, respectively.
Anchored 5h RACE. Cells in a 60 mm dish were harvested 48 h after transfection with one of the CAT plasmids. Total RNA was isolated and treated extensively with DNase I. The quantities of both the preC and C mRNA were determined by anchored-RACE (Edwards et al., 1991) . cDNA was synthesized with primer B78 using reverse transcriptase (Superscript II, Gibco) and appended buffer. After removal of RNA by adding a 1\10th vol. of 2 M NaOH and incubation at 50 mC for 30 min, excess primers and dNTP were removed by passage through an agarose column (Chromaspin-100, Funakoshi) and the cDNA was ligated with a 5h phosphorylated and 3h aminated 46-mer anchor deoxyoligonucleotide, B100 (5h PO % -GCACTTGACTAGGATCCACTGAATTCTTTAGTG-AGGGTTAATTGCC-NH # ), using T4 RNA ligase (Takara). After a 24 h ligation reaction in 10 µl of reaction mixture at 16 mC, half of the mixture was used for the first PCR with primers B101 (5h GGCAATTAACCC-CTCACTAAAG) and UT3 (5h AAAGGCCGTAATATCCAGC), which anneal with the anchor and cDNA, respectively. The EcoRIand BamHIdigested PCR products were cloned into pUC19, and the 3h end of the cDNA was determined by dideoxy nucleotide sequencing (Amersham).
Results

Reduced viral antigen production and replication of the preC-C promoter deletion mutant
To clarify how the previously reported nucleotide deletions in the preC-C promoter are associated with the markernegative phenotype, homogeneous tandem dimers of the whole HBV genome with deletions in the preC-C promoter region were created (Fig. 1A ). p2W8d has a homogeneous tandem dimer of HBV DNA (from wt p2UCP) bearing an 8 bp deletion (8d) from position 1763 to 1770 located between the second (1757 to 1762) and third (1789 to 1795) AT-rich regions in the preC-C promoter. This deletion has been found in several HBeAg-negative infections (Repp et al., 1992 ; Laskus et al., 1994 ; Feitelson, 1994 ; Okamoto et al., 1994) . p2W20d has a homogeneous tandem dimer of HBV DNA bearing a 20 bp deletion (20d) from 1853 to 1772. This deletion has been also found in several HBeAg-negative infections (Okamoto et al., 1994) . 20d disrupts the first (1752 to 1755) and second ATrich regions. Both 8 bp and 20 bp mutations prematurely terminate the X ORF at codons 135 and 131, respectively (Fig. 1B) .
When introduced into HepG2 cells, p2W8d produced HBsAg and HBeAg at levels detectable by ELISA. However, the quantities of HBsAg and HBeAg 72 h after transfection were 26 % and 15 %, respectively, of the amounts produced with p2UCP (Table 1 ). The mutation also reduced the amount of HBcAg relative to wt (40 %). With p2W20d, quantities of HBsAg (37 %), HBcAg (86 %) and HBeAg (5 %) were reduced compared to those of p2UCP. Plasmid ∆C was used as a negative control for HBeAg and HBcAg production, and produced HBsAg at the same level as p2UCP. Similar differences in antigen titres for these four HBV DNAs were observed with the HuH7 hepatoma cell line (not shown). Southern blotting of progeny virus DNA in the culture medium showed that HepG2 cells transfected with p2W8d or p2W20d released equal or greater amounts of DNA than those transfected with p2UCP (Fig. 2) .
Therefore, the deletions in the preC-C promoter region are responsible for the reduced production of HBsAg, HBcAg and HBeAg, but appear not to affect production of progeny virus in vitro.
Induction of viral antigen production of the mutated HBV DNA by co-transfected HBV DNA bearing the intact X gene
Most clinical cases in which only a deletion mutant was detected have been reported to harbour low HBV DNA titres in their serum, whereas the titres vary among those infected with both mutant and wt viruses. To address how the mutants interact with a wt virus, trans-complementation experiments were performed. When p2W20d was co-transfected with a limited amount of p2UCP (ratio 9 : 1), production of HBsAg, HBcAg and HBeAg was enhanced 5-, 5-and 2n5-fold, respectively, over the amounts produced with p2W20d alone (transfection numbers TF 1 and 2 in Table 2 ). The HBcAg titre of this mixed transfection was higher than that of p2UCP alone (TF 4). Increased antigen production was also observed when p2W20d was co-transfected with a small amount of ∆C, which has defective preC and C ORFs but bears intact X, preS-S and pol genes (TF 1 and 3) .
Restriction fragment length polymorphism of the PCR products of the encapsidated (nuclease S7-resistant) and DpnIresistant HBV DNA purified from the culture medium showed that the mutant progeny predominated (Fig. 3) . Thus, augmented viral antigen production in the co-transfection is predominantly due to increased gene expression of deletion mutants. Amplification of co-transfected wt or ∆C DNA template is unlikely to be the cause of enhanced antigen production.
CAT ELISA and 5h RACE of the mutant promoter region
Both preC and C promoter activities were quantified using the CAT gene as a reporter in order to eliminate any possible contribution by the truncated HBx protein. pWI.d5hCAT and BEIC its derivatives harbour either a wt or a mutated 170 bp fragment from positions 1630 to 1799. The authentic 22 bp 5h UTR for the preC gene was replaced with a hybrid 5h UTR containing 8 bp of the preC gene and 14 bp of the CAT gene. Therefore, only transcripts that are initiated upstream from the CAT initiation codon (the preC initiation codon equivalent) can be translated. Thus, the p.d5hCAT series tests preC promoter activities (Fig. 4A ). Transfections of HepG2 cells with plasmids bearing mutated preC promoter regions resulted in less CAT antigen production (p8d.d5hCAT, 20 % ; p20d.d5hCAT, 10 %) than in those transfected with the wt construct (pWI.d5hCAT) (Fig. 4B ). The p.79.CAT series carries a mutated 216 bp fragment from position 1630 to 1846 (Fig. 4A) . The inserted promoter fragments contain the initiation codon of the HBeAg precursor, but this reading frame terminates at the TAA codon 13 bp upstream from the CAT initiation codon. Thus, the titre of CAT in HepG2 should reflect only the C transcript equivalents, which start downstream from the preC initiation codon at 1814. Transfection with the mutated plasmids, p8d.79.CAT and p20d.79.CAT produced the same amount of CAT as did pWI.79.CAT (Fig. 4C) .
To determine if differences in CAT titre are due to differences in the quantity of transcript, the length of 5h UTR, or both, semiquantitative 5h RACE was performed. Agarose gel electrophoresis of RACE products of CAT mRNA of p8d.79.CAT and p20d.79.CAT showed markedly reduced preC mRNA-equivalents (Fig. 5A, B) . Moreover, 4-fold increases in C mRNA equivalents of both mutants were found (Fig. 5A, B) . The RACE product for the preC transcript of p8d.79.CAT was slightly shorter than that of pWI.79.CAT (Fig. 5B ). Nucleotide sequencing of preC equivalent RACE products of p8d.79.CAT showed 6 to 10 bp downstream shifts of its initiation site (Fig. 5C ). Attempts to clone the preC RACE products of p20d.79.CAT, which were not visible in an ethidium bromide staining, were unsuccessful. The initiation sites of C transcript-equivalents of the wt and both mutant constructs were at the same position, 1817 (Fig. 5C ). 
Discussion
It has been demonstrated that an HBx deleted at the carboxyl-terminal end from aa 130 does not function as a transacting transcriptional activator (Takada & Koike, 1994) . In this study, co-transfection of p2W20d with the intact X gene (either wt or ∆C) showed enhanced production of antigens by p2W20d ( Table 2) . The wt as well as mutated preC and C promoter activities in CAT plasmids (p.d5hCAT and p.79.CAT series) were enhanced by co-transfected p2UCP (unpublished observation). Therefore, the disruption of the X gene ORF, rather than an augmentation of the C promoter basal activity, causes the reduction of HBcAg production. Reduction of HBeAg is due to both the altered X gene and reduced preC promoter activity. Also, the shortened 5h UTR of preC mRNA of p2W8d may contribute to reduced HBeAg production by lessening translation efficiency.
BEIE
This study provides evidence that the 8d and 20d mutations are responsible for the reduced production of HBsAg, HBcAg and HBeAg, as predicted by clinical observations. Unexpectedly, however, equal or increased amounts of virionassociated DNA were detected in the culture medium of the mutants. Although C protein production is reduced by the mutations, it may be sufficient to encapsidate all of the transcribed pregenomes. The inhibitory role of the HBeAg precursor in the proliferation process has been shown by Lamberts et al. (1993) . In the present experiment, the reduction in HBeAg might have facilitated the encapsidation and\or reverse transcription of the mutant pregenomes.
The 8d mutation down-regulated preC promoter activity and shifted its initiation site 6 to 10 bp downstream. The 20d mutation down-regulated preC promoter activity to an undetectable level (Fig. 4B) . These results suggest that the second AT-rich region from 1757 to 1762 determines the preC mRNA initiation sites. This differs from a previous report describing the initiator function of the third AT-rich region from 1789 to 1795 for preC transcription (Chen et al., 1995) . The observed difference in the importance of the third AT-rich region might be due to difference in plasmid construction. In this study, the basic preC-C promoter region was cloned in a CAT-basic plasmid, while Chen et al. (1995) used only the third AT-rich region and it was cloned downstream of a strong exogenous enhancer. Since the preC initiation sites appear more varied when RNA was isolated from cells transfected with the whole genome (unpublished observation), the mechanism controlling preC transcription initiation may be more complex than initially suggested by preC-C promoter studies.
C promoter activity was upregulated to a small extent by both deletions, and no alteration of the initiation site was observed (Fig. 4B) . Thus, it appears that the C transcription start site is determined by the third AT-rich region, as demonstrated by Chen et al. (1995) . The upstream transcripts including C itself, preS-S, preX-X and the nearest preC can competitively inhibit the formation of the transcriptional complex at the C transcription start point (promoter occlusion) (Schaller & Fischer, 1991) . Thus, it appears reasonable to speculate that the reduction in preC transcription caused by the mutations favoured the transcription of the C gene.
Reduced production of HBsAg, HBcAg and HBeAg might enable the mutant viruses to escape immunodetection. Such mutants might have emerged in a quasispecies infection : either an acute infection with both wt and mutants at the same time, or a primary infection with a wt followed by chronic infection with its unmutated and mutant progeny. The mutant virus might be able to replicate and be selected while the host was acquiring immune competence to the viral proteins. Whether such a deletion mutant alone is infectious is not known. HBx has been demonstrated to be indispensable for the establishment of woodchuck hepatitis virus (WHV) infection of woodchuck (Chen et al., 1993 ; Zoulim et al., 1994) , although the amount of WHV genome has not been evaluated with a sensitive PCR. In contrast, the existence of HBV carriers who are negative for any virus marker (Feitelson, 1994) suggests that the deletion mutant alone could establish an infection. Thus, further studies are needed to address the impact of these mutant viruses in the development of hepatitis.
